A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients
Clinical trial NCT01387958 · TERMINATED
Trial details
- NCT number
- NCT01387958
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.